Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Equity Average (2022 - 2025)

Core Laboratories (CLB) has 4 years of Equity Average data on record, last reported at $269.3 million in Q3 2025.

  • For Q3 2025, Equity Average rose 7.28% year-over-year to $269.3 million; the TTM value through Sep 2025 reached $269.3 million, up 7.28%, while the annual FY2024 figure was $243.8 million, 16.43% up from the prior year.
  • Equity Average reached $269.3 million in Q3 2025 per CLB's latest filing, up from $263.3 million in the prior quarter.
  • Across five years, Equity Average topped out at $269.3 million in Q3 2025 and bottomed at $178.5 million in Q3 2022.
  • Average Equity Average over 4 years is $230.6 million, with a median of $233.6 million recorded in 2024.
  • Peak YoY movement for Equity Average: rose 25.76% in 2023, then rose 7.28% in 2025.
  • A 4-year view of Equity Average shows it stood at $186.1 million in 2022, then grew by 23.37% to $229.6 million in 2023, then grew by 11.95% to $257.1 million in 2024, then increased by 4.76% to $269.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $269.3 million in Q3 2025, $263.3 million in Q2 2025, and $258.5 million in Q1 2025.